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Background: The presence of diabetes mellitus poses a challenge in the treatment of patients with acute
myocardial infarction (AMI). We aimed to evaluate the sex-specific outcomes of diabetic and non-diabetic patients
with AMI who have undergone percutaneous coronary intervention (PCI).
Methods: Data of the Estonian Myocardial Infarction Registry for years 2006–2009 were linked with the Health
Insurance Fund database and the Population Registry. Hazard ratios (HRs) with the 95% confidence intervals (CIs) for
the primary composite outcome (non-fatal AMI, revascularization, or death whichever occurred first) and for the
secondary outcome (all cause mortality) were calculated comparing diabetic with non-diabetic patients by sex.
Results: In the final study population (n = 1652), 14.6% of the men and 24.0% of the women had diabetes. Overall,
the diabetics had higher rates of cardiovascular risk factors, co-morbidities, and 3–4 vessel disease among both
men and women (p < 0.01). Among women, the diabetic patients were younger, they presented later and less
often with typical symptoms of chest pain than the non-diabetics (p < 0.01). Women with diabetes received aspirin
and reperfusion for ST-segment elevation AMI less often than those without diabetes (p < 0.01). During a follow-up
of over two years, in multivariate analysis, diabetes was associated with worse outcomes only in women: the adjusted
HR for the primary outcome 1.44 (95% CI 1.05 − 1.96) and for the secondary outcome 1.83 (95% CI 1.17 − 2.89). These
results were largely driven by a high (12.0%) mortality during hospitalization of diabetic women.
Conclusions: Diabetic women with AMI who have undergone PCI are a high-risk group warranting special attention in
treatment strategies, especially during hospitalization. There is a need to improve the expertise to detect AMI earlier,
decrease disparities in management, and find targeted PCI strategies with adjunctive antithrombotic regimes in
women with diabetes.
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Patients with acute myocardial infarction (AMI) have a
worse short- and long-term prognosis than the general
population [1,2]. During the last decades innovations in
the treatment strategies, including the use of percutan-
eous coronary interventions (PCI) have considerably
improved the prognosis [3-5]. However, women still
have higher rates of complications compared with men,
although the differences are often explained by their
more adverse cardiovascular profile [6,7]. In particular,
the presence of diabetes mellitus (DM) poses a challenge
in the treatment of both sexes [8]. Previous studies have
shown an interaction between sex and diabetes for con-
gestive heart failure [9,10]. However, studies addressing
the sex-specific impact of diabetes on the outcomes after
AMI have included unselected cohorts where only a pro-
portion of patients have undergone PCI [8,11,12]. Still,
this may be the underlying cause for differences in sex-
specific outcomes [13]. Furthermore, these studies have
mostly concentrated on all-cause mortality only.
The aim of our study was to evaluate the sex-specific
outcomes in terms of non-fatal AMI, revascularization,
and all-cause mortality in diabetic and non-diabetic
patients with AMI who have undergone PCI.
Methods
We conducted a register linkage study by linking data
from the following registries: the Estonian Myocardial
Infarction Registry (EMIR), the Estonian Health Insur-
ance Fund (EHIF) database, and the Estonian Population
Registry (EPR). The study was approved by the Research
Ethics Committee of the University of Tartu and by the
Data Protection Inspectorate of Estonia.
The EMIR is a prospective registry including data on
all consecutive patients hospitalized with the diagnosis
of AMI [main diagnosis code I21 − I22 according to the
International Statistical Classification of Diseases and
Related Health Problems 10th revision (ICD-10), [14].
The data collection in the EMIR complies with the Car-
diology Audit and Registration Data Standards in Europe
[15]. In the EMIR patients are classified as diabetic if
they have a history of diabetes documented by a phys-
ician or the patients are diagnosed with diabetes during
the current episode.
For the purpose of this study, we included consecutive
AMI cases hospitalized into a tertiary care PCI centre,
Tartu University Hospital, from 1 January 2006 until 31
December 2009. According to the internal audit con-
ducted for the purpose of this study, the case coverage
for the study period was 99.8%. We included only
patients who underwent PCI during the index hospi-
talization. If a patient was admitted several times with
AMI during the study period, we included only the first
case of hospitalization into the study. EMIR providedthe following data: (a) patient baseline characteristics
(including diagnosis of diabetes), (b) prescription of
medications during hospitalization and for outpatient
use, (c) use of coronary angiography, revascularization,
and echocardiography during the index hospitalization,
(d) in-hospital outcomes.
Data on mortality during the follow-up were obtained
from the EPR.
Data on the non-fatal AMI and repeated revasculariza-
tion during follow-up were provided by the EHIF. In the
Estonian health insurance system 95% of the 1.3 million
inhabitants are insured. Consistency in reporting to the
EHIF database and the validity of the data has been
established [16]. Data on non-fatal AMI included the
date of hospitalization and the diagnosis code according
to the ICD-10 classification (I21 − I22, main diagnosis).
The EHIF provided the data on the method and date of
revascularization according to the Nordic Medico-
Statistical Committee Classification of Surgical Proce-
dures, version 1.6: percutaneous coronary intervention
(procedure code FNG with numeric characters of the
code) and coronary artery bypass graft (procedure codes
FNA, FNC, and FNE with numeric characters of the
codes) [17].
Study outcomes
The primary composite outcome was defined as non-
fatal AMI, repeated revascularization (coronary artery
bypass-grafting; target or new lesion PCI), or all-cause
mortality whichever occurred first. The follow-up started
on the date of the PCI during the index hospitalization
and ended if a case reached the primary outcome or the
follow-up time ended (31 December 2010). We also
studied all-cause mortality separately as a secondary out-
come. For all-cause mortality the follow-up ended when
the patient died or reached the date for the end of the
follow-up.
Statistical analysis
Categorical variables were expressed as percentages, and
continuous variables as means and standard deviations
(SDs), or as medians and interquartile ranges (IQRs). To
compare the diabetic and non-diabetic patients by sex in
respect to the baseline characteristics, procedural char-
acteristics of PCI, prescription of medications, and out-
comes the Chi-Square test for categorical variables and
t-test for two independent samples or the Wilcoxon-
Mann–Whitney test for continuous variables were used.
We used Cox’s proportional hazards regression to cal-
culate hazard ratios (HRs) of primary and secondary
outcome with the 95% confidence intervals (CIs) to
compare outcomes of diabetic to non-diabetic patients
by sex. In multivariate analysis the potential confounders
from Table 1 were entered into the model if they were
Table 1 Baseline characteristics of men and women with and without diabetes who have undergone percutaneous
coronary intervention
Men Women
Non-DM n = 905 DM n = 155 p Non-DM n = 450 DM n = 142 p
Mean age± SD (years) 63.1 ± 12.0 65.0 ± 9.4 0.055 71.9 ± 9.9 69.3 ± 9.6 0.006
STEMI, % 66.9 63.2 0.378 70.2 62.0 0.066
Arterial hypertension, % 61.9 80.7 <0.001 76.4 91.6 <0.001
Dyslipidemia, % 64.3 62.5 0.679 72.7 69.7 0.495
Current smoking, % 44.2 30.3 0.001 14.2 7.0 0.024
Previous AMI, % 18.2 32.3 <0.001 15.8 25.4 0.010
Chronic heart failure, % 13.7 25.8 <0.001 12.4 29.6 <0.001
Previous stroke, % 5.4 9.0 0.078 5.3 7.8 0.288
Peripheral vascular disease, % 9.8 17.4 0.005 7.6 8.5 0.728
Previous PCI, % 8.7 20.7 <0.001 5.8 9.2 0.157
Previous CABG, % 4.3 3.9 0.802 2.4 3.4 0.025
Killip III − IV on admission, % 8.1 12.9 0.049 7.1 14.1 0.010
LVEF <40%, % 14.1 20.0 0.059 13.1 15.5 0.471
3 − 4 vessel disease, % 43.7 54.2 0.015 45.3 64.1 <0.001
Delay to FMC (hrs), %
≤4 52.8 49.7 0.210 54.7 42.3 0.015
5–24 28.8 35.5 28.4 31.7
>24 18.3 14.8 16.9 26.1
AMI = acute myocardial infarction; CABG = coronary artery bypass graft surgery; DM = diabetes mellitus; FMC = first medical contact; LVEF = left ventricular
ejection fraction; PCI = percutaneous coronary intervention; STEMI = ST-segment elevation myocardial infarction.
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a p < 0.05 between diabetic and non-diabetic patients of
either gender. The assumption of proportional hazards
assumed in the Cox proportional hazards model was
assessed graphically. In our regression model we did not
control for the recommendation of medical therapy be-
cause the timing of medication administration could not
be determined from our methods of data abstraction,
nor could we account for confounding by treatment in-
dication given the study’s nonrandomized nature.
Two-sided p values < 0.05 were considered statistically
significant. All analyses were performed using the Stata
statistical software version 11 [18].
Results
Of the 2330 patients with AMI hospitalized during the
study period 1060 (74.7%) men and 592 (65.1%) women
underwent PCI during the index episode (p < 0.001) and
were included into the study. In the final study popula-
tion 155 (14.6%) men and 142 (24.0%) women had dia-
betes (p < 0.001).
The baseline characteristics during the index
hospitalization for men and women with and without
diabetes are presented in Table 1. Overall, the patients
with diabetes had higher rates of cardiovascular risk fac-
tors, co-morbidities, and 3–4 vessel disease among bothmen and women. Women with diabetes were younger
and had longer delay times to first medical contact than
those without diabetes. Among men 79.3% of non-
diabetic and 77.4% of diabetic patients presented with
typical symptoms of chest pain (p = 0.588). In women,
those with diabetes presented less frequently with typical
symptoms of chest pain than those without diabetes,
respectively 68.3% and 79.3% (p = 0.007).
During the index hospitalization among women with
ST-segment elevation myocardial infarction (STEMI) a
significantly lower proportion of patients with diabetes
than those without received reperfusion within 12 hours
after symptom onset (Table 2). When assessing the
utilization of medications during the index hospitaliza-
tion, women with diabetes were found to receive aspirin
less often than those without diabetes (Table 3). Men
with diabetes received more often treatment with
angiotensin-converting enzyme inhibitors and/or angio-
tensin II receptor blockers than men without diabetes.
The rates of recommendation of the studied drugs for
out-patient treatment were similar to the rates of drug
utilization during the index hospitalization, though
no differences within sex-groups were observed (data
not presented).
The median follow-up time for the primary outcome
was 2.1 years (IQR 0.8 − 3.4) and for the secondary
Table 2 Procedural characteristics of percutaneous coronary intervention during the index hospitalization for men and
women with and without diabetes
Men Women
Non-DM % DM % p Non-DM % DM % p
STEMI n = 605 n = 98 n = 316 n = 88
Reperfusion within 12 hrs after symptom onset 72.1 67.4 0.337 75.0 60.2 0.006
Method of reperfusion*
Fibrinolysis 15.6 18.2 0.593 11.0 11.3 0.941
Primary PCI 84.4 81.8 89.0 88.7
NSTEMI n = 300 n = 57 n = 134 n = 54
Timing of PCI
≤ 2 hrs after admission 18.0 7.0 0.039 17.2 14.8 0.694
≤ 12 hrs after admission 71.0 64.9 0.358 67.9 64.8 0.683
DM = diabetes mellitus; NSTEMI = non-ST-segment elevation myocardial infarction; PCI = percutaneous coronary intervention; STEMI = ST-segment elevation
myocardial infarction.
*Among those who received reperfusion.
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between the sex-groups. In univariate analysis, patients
with diabetes both among men and women had a higher
risk of primary and secondary outcome (Tables 4 and 5).
In multivariate analysis, however, diabetes was associated
with a higher risk of primary and secondary outcome
only in women (Table 5). The Figures 1 and 2 demon-
strate the cumulative hazards of the outcomes in dia-
betic and non-diabetic patients by sex.
The in-hospital mortality of women with diabetes was
three times higher than that of the men with diabetes,
respectively 12.0% and 3.9% (p = 0.009). The overall
rates of cardiogenic shock (4.5%), bleeding complications
(4.4%), mechanical complications (4.4%), and stroke
(0.7%) during the index hospitalization were low.
Discussion
This register linkage study demonstrates that among
patients with AMI who have undergone PCI, diabetes is
associated with significantly worse outcomes in womenTable 3 Utilization of medications during the index hospitaliz
who have undergone percutaneous coronary intervention
Medications Men




Heparin group 96.1 96




ACEI = angiotensin-converting enzyme inhibitors; ARB = angiotensin II receptor blothan in men compared to those without diabetes. This
excess risk seems to be largely driven by a high in-hospital
mortality of women with diabetes.
There are few studies on this particular subject. Most
of them have included mixed cohorts of patients with
stable and unstable coronary artery disease undergoing
PCI [8,11-13,19-21]. The results are in accordance with
our findings and collectively suggest that the worse
effect of diabetes on the outcomes in women might be
related to the onset mechanisms of AMI, the procedural
success of PCI as well as to the higher burden of cardio-
vascular disease (CVD) risk factors. Rosengren et al. [20]
attributed much of the excess mortality in young women
of less than 50 years of age to diabetes. The study of
Champney et al. [21] demonstrated that the overall
stronger effect of diabetes among women was more pro-
nounced in the 1990ies than in the more recent years.
These findings could be associated to the developments
in the treatment strategies of high risk patients undergo-
ing PCI.ation for men and women with and without diabetes
Women
= 155 p Non-DM n = 450 DMn = 142 p
% %
.4 0.425 99.3 96.5 0.010
.8 0.156 93.3 90.9 0.319
.8 0.699 96.0 96.5 0.797
.4 0.542 32.9 29.6 0.461
.6 0.294 79.6 76.8 0.477
.7 0.017 86.7 84.5 0.516
.8 0.816 75.8 73.9 0.658
ckers; DM = diabetes mellitus.
Table 4 Outcomes during the follow-up among men and women with and without diabetes who have undergone
percutaneous coronary intervention
Men Women
Non-DM n = 905 DM n = 155 p Non-DM n = 450 DM n = 142 p
% % % %
Primary outcome 37.6 49.7 0.004 36.0 52.1 0.001
Non-fatal AMI 9.9 12.3 7.3 12.0
Revascularization 11.9 18.6 10.4 12.7
Death 15.7 19.4 18.2 27.5
Secondary outcome 18.2 23.8 0.099 18.7 29.6 0.006
Death during hospitalization 5.3 3.9 0.453 5.8 12.0 0.013
AMI = acute myocardial infarction; DM = diabetes mellitus.
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only be a risk equivalent of a previous CVD but may ac-
tually confer a greater risk among women [22]. This
could be explained by the fact that women and diabetics
are more prone to develop diffuse small-vessel disease
and therefore have more frequently diabetic cardio-
myopathy. In addition, there are some fundamental
biological differences in the composition of the athero-
sclerotic plaque between men and women [23-26]. So
when a CVD event such as AMI occurs, women with
diabetes have a worse prognosis due to a more serious
underlying coronary artery disease and a more depressed
myocardial function. Also the role of the lack of the
ovarian hormones with cardiovascular protective effects
in postmenopausal women is much discussed [27]. The
mechanisms associated with the onset of AMI may
be compromised to a greater extent in women than in
men with diabetes as there are sex differences in the
endothelial dysfunction, myocardial contractile function,
neuroendocrinal regulatory mechanisms, sensitivity to
aggregating stimuli of platelets, and tolerance to stress
[27-30]. Conflicting results exist on the sex-specific asso-
ciation between admission hyperglycemia and the risk
of in-hospital mortality in patients with AMI [31,32].
Still, the study of Kawamoto et al. [33] suggest that
women have a more pronounced inflammatory reaction
to hyperglycemia than men, making women with dia-
betes a high risk group for cardiovascular adverse eventsTable 5 Crude and adjusted hazard ratios for outcomes durin
among men and women with diabetes compared to those wi
Outcome Men
HR (95% CI) AHR (95% C
Primary¥ 1.54 (1.20 − 1.98)* 1.29 (0.98 − 1
Secondary€ 1.53 (1.06 − 2.20)* 1.19 (0.80 − 1
AHR = hazard ratio; adjusted for age, AMI subtype (STEMI or NSTEMI), arterial hyper
previous stroke, peripheral vascular disease, previous PCI, previous CABG, Killip clas
of diseased vessels (1–2 or 3–4 vessel disease), delay to first medical contact.
¥Primary outcome = non-fatal AMI, revascularization, or all-cause mortality.
€Secondary outcome = all-cause mortality.
*p < 0.05.[34]. Furthermore, in women a higher rate of procedural
complexity, peripheral complications, and bleeding after
PCI has been reported [35].
There are several issues concerning the baseline char-
acteristics that should be addressed when assessing the
sex-specific outcomes of diabetic patients in the given
study. Firstly, the female diabetic patients presented later
and less often with typical symptoms of chest pain com-
pared to the non-diabetics. Secondly, although the
women with diabetes were younger, the rates of previous
AMI and chronic heart failure were higher than in those
without diabetes. As Norhammar et al. [36] demonstrate
the poorer outcomes of younger women with diabetes
compared to men are to a large extent related to an
increased risk factor burden. Still, also the older women
with diabetes seem to have a disadvantage compared to
older men. The study of Leosdottir et al. [37] indicated
that the older women with diabetes have a more pro-
nounced risk factor clustering and worse self-rated
health than older men. This adds to the excess cardio-
vascular risk of women with diabetes and in combin-
ation with the higher age could be the contributing
factor for sex-specific outcomes of patients with dia-
betes. Therefore, in order to alleviate this unfavorable
situation for women with diabetes, the improvements
should target already the primary prevention strategies
of AMI. The medical professionals as well as the patients
with CVD should be more aware of the wider prevalenceg follow-up after percutaneous coronary intervention
thout diabetes
Women
I) HR (95% CI) AHR (95% CI)
.68) 1.60 (1.21 − 2.13)* 1.44 (1.05 − 1.96)*
.76) 1.65 (1.11 − 2.44)* 1.83 (1.17 − 2.89)*
tension, dyslipidemia, current smoking, previous AMI, chronic heart failure,
s III − IV on admission, left ventricular ejection fraction <40%, and the number
Figure 1 Cumulative hazards of primary outcome (non-fatal AMI, repeated revascularization, or all-cause mortality whichever occurred
first) in men and women with and without diabetes during follow-up after percutaneous coronary intervention. CI = confidence interval;
DM = diabetes mellitus group; HR = hazard ratio; PCI = percutaneous coronary intervention.
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wards shorter pre-hospital delay times.
The study by Krämer et al. [38] suggests that the sex
differences in the AMI mortality of patients with dia-
betes may be due to the fact that the diabetic men with
CVD might be more thoroughly treated compared to
the women. Interestingly, it has also been shown, that
the control of hyperglycaemia and major CVD risk fac-
tors is less satisfactory in women than men [39]. In our
study aspirin was recommended less frequently for
women with diabetes than for those without. The ana-
lysis also showed that in women with STEMI, those with
diabetes received less often reperfusion within 12 hours
after symptom onset than those without diabetes. In the
future research it is essential to identify the reasons for
these disparities as they lead to larger infarct sizes,Figure 2 Cumulative hazards of secondary outcome (all-cause mortal
up after percutaneous coronary intervention. CI = confidence interval;
coronary intervention.development of congestive heart failure, and decreased
survival. Moreover, the success rate of primary PCI has
been shown to be lower in women and in patients with
diabetes [40,41].
When assessing the overall rates of outcomes it should
be recognized that patients with AMI who have undergone
PCI have a poor prognosis. With a median follow-up time
of more than two years, almost half of the study population
experienced a primary outcome event and by the end of
the follow-up a fourth of the patients were dead. This
emphasizes the need of cardiovascular risk adjusted life-
style changes and proper use of guideline-recommended
medications in the treatment of CVD and other co-
morbidities such as diabetes in patients after AMI.
The strengths of our study are the use of an unselected
real-life cohort of patients from a national register, theity) in men and women with and without diabetes during follow-
DM = diabetes mellitus group; HR = hazard ratio; PCI = percutaneous
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AMI and revascularization as an outcome measure in
addition to all-cause mortality.
We acknowledge the limitations of this study. Firstly,
this is a register linkage study and there may be con-
founders that we were not able to adjust for, including
consistence in the use of prescribed drugs after
hospitalization. Secondly, we do not have detailed data
on the type and duration of diabetes as well as the spe-
cific treatment and adequacy of glycaemic control in
patients with diabetes during the index hospitalization
and after hospital discharge. Thirdly, while suggestive of
a sex difference in prognosis associated with diabetes,
our epidemiological findings do not explain the possible
pathological mechanisms underlying such a difference.
Furthermore, the rates of non-fatal in-hospital complica-
tions are low and do not enable us to study the immedi-
ate causes of death in a systematic manner. Fourthly, the
issue of selection bias arises as only a proportion of
patients with an AMI, more frequently men, underwent
PCI. Clinicians tend to refer younger patients with less
co-morbidities for invasive procedures. Therefore the
patients selected for PCI in our study should have a
lower risk than those not selected; this applies both to
men and women. However, as the women with AMI
tend to be older and have a higher risk factor burden,
the differences in the baseline characteristics between
men and women persist. Nevertheless, this is an obser-
vational study reflecting management of patients with
AMI in real life and we cannot exclude a possible selec-
tion bias. Still, in case of a selection bias the real mortal-
ity risks of the women selected for PCI, would be
underestimated. Fifthly, as the differences in the out-
comes are easier to be shown in a high-risk population
than in low or intermediate-risk populations, the out-
come differences among men could reach statistical sig-
nificance in a larger study cohort. However, the number
of men in the study was twice as high as that of the
women. So in case worse outcomes for men with dia-
betes compared to those without could be demonstrated,
the effect would be of low clinical importance.
Conclusions
Diabetic women with AMI who have undergone PCI are
a high-risk group warranting special attention in treat-
ment strategies, especially during hospitalization. There
is a need to improve the expertise to detect AMI earlier,
decrease disparities in management, and find targeted
PCI strategies with adjunctive antithrombotic regimes in
women with diabetes.
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